| 國立成功大學 |
2023 |
Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth
|
Wang, K.;Liao, P.-Y.;Chang, W.-C.;Yang, C.-R.;Su, Y.-T.;Wu, P.-C.;Wu, Y.-C.;Hung, Y.-C.;Akhtar, N.;Lai, H.-C.;Ma, W.-L. |
| 臺大學術典藏 |
2022-09-15T01:09:05Z |
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study
|
Ma W.-L.; Chia-Chi Lin; Hsu F.-M.; Lee J.-M.; Chen J.-S.; Hsieh M.-S.; Chang Y.-L.; Chao Y.-T.; Chang C.-H.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2022-07-26T08:09:28Z |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens
|
Ma W.-L.; Lin C.-C.; Hsu F.-M.; Lee J.-M.; Chen J.-S.; Huang Y.-L.; YIH-LEONG CHANG; Chang C.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-07-20T06:33:49Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.; Chen Y.-K.; Tang J.-L.; Tsay W.; PO-TING YEH; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2022-07-15T06:43:09Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.; Chen Y.-K.; Tang J.-L.; Tsay W.; Yeh P.-T.; CHUNG-MAY YANG; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2022-05-11T07:47:51Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.|YIN-KAI CHEN; Tang J.-L.; Tsay W.; Yeh P.-T.; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2022-03-10T06:15:01Z |
Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectives
|
Chang D.-Y.; Ma W.-L.; YEN-SHEN LU |
| 臺大學術典藏 |
2022-01-14T03:59:34Z |
Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2
|
Ma W.-L.; Chou C.-H.; JO-PAI CHEN; Kuo S.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:26Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; HSIN-AN HOU; Hsu Y.-J.; Chen Y.-K.; Tang J.-L.; Tsay W.; Yeh P.-T.; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 國立成功大學 |
2022 |
A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids
|
Yang, C.-R.;Liang, C.-T.;Tsai, S.-C.;Wu, Y.-C.;Liu, C.-W.;Yang, H.-H.;Tu, Tu T.-Y.;Lee, Y.-C.;Hsiao, K.-Y.;Chang, W.-C.;Ma, W.-L. |
| 國立成功大學 |
2022 |
Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma
|
Yu, Yu Y.-C.;Ahmed, Ahmed A.;Lai, H.-C.;Cheng, W.-C.;Yang, J.-C.;Chang, W.-C.;Chen, L.-M.;Shan, Y.-S.;Ma, W.-L. |
| 臺大學術典藏 |
2021-10-14T02:45:38Z |
Vitamin D receptor-binding site variants affect prostate cancer progression
|
Lin V.C.; Huang S.-P.; Ting H.-J.; Ma W.-L.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-09-04T03:10:19Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Ma W.-L.; Yao M.; SHU-LANG LIAO; Tang J.-L.; Wang Y.-C.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Ma W.-L.; Yao M.; Liao S.-L.; Tang J.-L.; Wang Y.-C.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:14Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-07-20T02:10:46Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.; CHEN YIN-KAI; Tang J.-L.; Tsay W.; Yeh P.-T.; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2021-03-05T09:38:14Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; CHUNG-WU LIN; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:19Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Ma W.-L.;Yao M.;Liao S.-L.;Tang J.-L.;Wang Y.-C.;Sung-Hsin Kuo;Cheng A.-L.; Ma W.-L.; Yao M.; Liao S.-L.; Tang J.-L.; Wang Y.-C.; SUNG-HSIN KUO; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:09Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.;Yeh K.-H.;Yao M.;Tang J.-L.;Lin C.-W.;Wang Y.-T.;Yeh Y.-C.;Wang H.-P.;Cheng A.-L.;Sung-Hsin Kuo; Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2021-02-23T08:26:09Z |
Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2
|
Ma W.-L.;Chou C.-H.;Chen J.-P.;Sung-Hsin Kuo; Ma W.-L.; Chou C.-H.; Chen J.-P.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.;Kun-Huei Yeh;Yao M.;Tang J.-L.;Lin C.-W.;Wang Y.-T.;Yeh Y.-C.;Wang H.-P.;Cheng A.-L.;Kuo S.-H.; Ma W.-L.; KUN-HUEI YEH; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-15T03:46:20Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:27Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.; Chen Y.-K.; JIH-LUH TANG; Tsay W.; Yeh P.-T.; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Wang Y.-C.; Kuo S.-H.; Cheng A.-L.; Ma W.-L.; Yao M.; Liao S.-L.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Cheng A.-L.; Kuo S.-H.; Yeh Y.-C.; Wang H.-P.; Wang Y.-T.; Lin C.-W.; JIH-LUH TANG; Yao M.; Yeh K.-H.; Ma W.-L. |
